Lungs News and Research

RSS

Researchers identify that KLF17 gene with Id1 gene can regulate breast cancer metastasis

Researchers at The Wistar Institute have identified a key gene (KLF17) involved in the spread of breast cancer throughout the body. They also demonstrated that expression of KLF17 together with another gene (Id1) known to regulate breast cancer metastasis accurately predicts whether the disease will spread to the lymph nodes.

6 Oct 2009

Kevetrin reduces tumor volume by 72%: Cellceutix

October is breast cancer awareness month with many supporters touting pink ribbons, but in health stocks investors are watching the market closely for news of new drugs in various stages of testing. Recently, Cellceutix announced its pharmaceutical compound Kevetrin reduced tumor volume by 72%, giving new hope for breast cancer patients.

6 Oct 2009

Depression leads to elevated inflammatory proteins in the human body: Study

To help solve this long standing chicken and egg conundrum, researchers led by Jesse Stewart, Ph.D., assistant professor of psychology at Indiana University-Purdue University Indianapolis asked two critical questions. Does depression lead to elevated inflammatory proteins in the human body? Or does an increase in these proteins lead to depression? They found that the answer to the first question appears to be "yes," and the answer to the second question may be "no" among healthy adults.

6 Oct 2009

Uncontrolled maternal asthma during pregnancy increases the likelihood of the child developing asthma

Expectant mothers who eschew asthma treatment during pregnancy heighten the risk transmitting the condition to their offspring, according to one of the largest studies of its kind published in the European Respiratory Journal.

5 Oct 2009

ArQule completes patient enrollment in ARQ 197 Phase 2 trial for non-small cell lung cancer

ArQule, Inc. (Nasdaq: ARQL) today announced that patient enrollment in a Phase 2 trial with ARQ 197 in non-small cell lung cancer (NSCLC) has been completed.

5 Oct 2009

Positive results from Peregrine's Phase II bavituximab trial for non-small cell lung cancer

Peregrine Pharmaceuticals, Inc. today reported additional positive results in its Phase II trial evaluating bavituximab in combination with carboplatin and paclitaxel in patients with non-small cell lung cancer (NSCLC). Data previously reported from the initial cohort of 21 patients in the study had indicated that 11 of 17 evaluable patients with locally advanced or metastatic NSCLC achieved an objective tumor response according to RECIST criteria.

5 Oct 2009

American Lung Association kicks off its Faces of Influenza campaign in Miami

The American Lung Association of Florida-South Area is kicking off its 2009-2010 Faces of Influenza initiative by conducting a public influenza panel discussion to help Miami area residents understand the seriousness of seasonal influenza and the importance of annual vaccination. The meeting will address the latest flu statistics and benefits of vaccination, especially among high-risk groups.

3 Oct 2009

Seattle Cancer Care Alliance launches TheDayIFoundOut website for cancer patients

The day a person is diagnosed with cancer is one of the most difficult days of his or her life. While the Internet holds an endless supply of cancer related information, for an overwhelmed and frightened person, genuine emotional support is often hard to find. TheDayIFoundOut(TM) is an online community featuring the faces and voices of cancer survivors offering empathy, insight, advice and resources to help cancer patients take the first crucial steps toward beating their disease.

3 Oct 2009

Study finds that visual impairment in T1D patients may be decreasing

People diagnosed with type 1 diabetes (T1D) in recent years are less likely to develop diabetes-related vision loss than those diagnosed in earlier years, says a new study funded by the National Eye Institute, a division of the National Institutes of Health. Forecasts of visual impairment prevalence in T1D patients may need to be amended, the researchers suggest, since current predictions assume that the earlier incidence rates will continue.

3 Oct 2009

Misuse of aspirin might have caused high death rate during 1918-1919 influenza pandemic

The devastation of the 1918-1919 influenza pandemic is well known, but a new article suggests a surprising factor in the high death toll: the misuse of aspirin. Appearing in the November 1 issue of Clinical Infectious Diseases and available online now, the article sounds a cautionary note as present day concerns about the novel H1N1 virus run high.

3 Oct 2009

Researchers study the role of CHRNA3 and CHRNA5 genes in lung cancer

A recent study published in the October 2009 issue of the Journal of Thoracic Oncology determined that variations of specific genetic markers identified in previous research, or SNPs, may indicate a greater lung cancer risk in African Americans than in whites. The genes CHRNA3 and CHRNA5 may contribute to lung cancer risk due directly or through their association with nicotine dependence.

3 Oct 2009

Study to determine vitamin D's effectiveness in pregnant women with asthma

A group of pregnant women who have asthma or allergies will get extra vitamin D as part of a study to determine if the vitamin can prevent their children from developing asthma.

3 Oct 2009

American Lung Association launches new smoking cessation campaign

The American Lung Association is launching a new smoking cessation campaign, "Quitter in You," designed to highlight the need to change the way Americans look at quitting.

3 Oct 2009

70% of Americans underestimate the seriousness of SCA

More than 250,000 deaths occur each year as a result of sudden cardiac arrest (SCA). In fact, SCA claims one life every two minutes, taking more lives each year than breast cancer, lung cancer or AIDS. Yet, according to a recent survey issued by the Heart Rhythm Society, more than 70 percent of Americans not only underestimate the seriousness of SCA, but also believe SCA is a type of heart attack.

3 Oct 2009

Quest PharmaTech acquires immunotherapeutic antibody products from Paladin Labs

Quest PharmaTech Inc. ("Quest" or the "Company"), a pharmaceutical company developing and commercializing products for the treatment of cancer, today announced that it has acquired a pipeline of late-stage immunotherapy product candidates from Paladin Labs Inc. ("Paladin").

3 Oct 2009

New strategic research service for the oncology market launched by Health Strategies Group

Health Strategies Group, a leading provider of market intelligence to the pharmaceutical and biotechnology industries, has just launched Oncology Performance Edge, a new strategic research service that helps marketing and sales executives in the oncology field improve brand performance by understanding how best to invest their resources.

3 Oct 2009

Make healthy housing a priority: NCHH

According to new research from the National Center for Healthy Housing (NCHH), the majority of U.S. families (67%) live in a home with at least one major health risk.

3 Oct 2009

Teens with chronic disease often have expensive, uncertain coverage

ABC News profiles teens living with chronic diseases, and examines their insurance coverage and the cost of such care. The article notes: "Chronic diseases affect 1 in 10 Americans and are the leading cause of disability, accounting for 70 percent of all deaths, according to the Centers for Disease Control and Prevention. They are also expensive."

3 Oct 2009

NEDD9 protein stimulates aggressive metastatic breast cancer

Researchers at Fox Chase Cancer Center have demonstrated that a protein called NEDD9 may be required for some of the most aggressive forms of breast cancer to grow. Their findings, based on the study of a mouse model of breast cancer, are presented in a recent issue of Cancer Research, available on-line now.

3 Oct 2009

FDA grants Fast Track designation to Corthera's relaxin for treating acute heart failure

Corthera Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to relaxin, the company's investigational drug for the treatment of acute heart failure (AHF). The Fast Track program facilitates the development and expedites the review of new drugs intended to treat serious or life-threatening conditions and that demonstrate the potential to address unmet medical needs.

3 Oct 2009

Lungs News and Research

Researchers identify that KLF17 gene with Id1 gene can regulate breast cancer metastasis

Kevetrin reduces tumor volume by 72%: Cellceutix

Depression leads to elevated inflammatory proteins in the human body: Study

Uncontrolled maternal asthma during pregnancy increases the likelihood of the child developing asthma

ArQule completes patient enrollment in ARQ 197 Phase 2 trial for non-small cell lung cancer

Positive results from Peregrine's Phase II bavituximab trial for non-small cell lung cancer

American Lung Association kicks off its Faces of Influenza campaign in Miami

Seattle Cancer Care Alliance launches TheDayIFoundOut website for cancer patients

Study finds that visual impairment in T1D patients may be decreasing

Misuse of aspirin might have caused high death rate during 1918-1919 influenza pandemic

Researchers study the role of CHRNA3 and CHRNA5 genes in lung cancer

Study to determine vitamin D's effectiveness in pregnant women with asthma

American Lung Association launches new smoking cessation campaign

70% of Americans underestimate the seriousness of SCA

Quest PharmaTech acquires immunotherapeutic antibody products from Paladin Labs

New strategic research service for the oncology market launched by Health Strategies Group

Make healthy housing a priority: NCHH

Teens with chronic disease often have expensive, uncertain coverage

NEDD9 protein stimulates aggressive metastatic breast cancer

FDA grants Fast Track designation to Corthera's relaxin for treating acute heart failure

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News